FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ATTENTION DEFICIT HYPERACTIVITY DISORDER: LABORATORY EFFECTS
Guardat en:
AMAN, M.G., ET AL., FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ATTENTION DEFICIT HYPERACTIVITY DISORDER: LABORATORY EFFECTS. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, Vol. 23, no. 3 (1993), p. 491-506.
Ref.
35588
Localització:
SIIS R.237
Palabras clave:
Autismo, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Efectos, Estudio descriptivo, Fármacos, Hiperactividad, Infancia, Trastornos de atención, Trastornos del espectro autista, EE.UU.
Autismo, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Efectos, Estudio descriptivo, Fármacos, Hiperactividad, Infancia, Trastornos de atención, Trastornos del espectro autista, EE.UU.
Ítems similars: FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ATTENTION DEFICIT HYPERACTIVITY DISORDER: LABORATORY EFFECTS
- Efficacy and safety of methylphenidate on attention deficit hyperactivity disorder in children with Down syndrome
- Expression alteration of neuroligin family gene in attention deficit and hyperactivity disorder and autism spectrum disorder
- FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND BORDELINE IQ: CLINICAL EFFECTS
- METHYLPHENIDATE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN BOYS WITH TOURETTE'S SYNDROME
- ADULTS' VERSUS CHILDREN'S PERCEPTIONS OF A CHILD WITH AUTISM OR ATTENTION DEFICIT HYPERACTIVITY DISORDER
- METHYLPHENIDATE TREATMENT OF HYPERACTIVE AUTISTIC CHILDREN